Related Experiment Videos
TNFA and TNFB polymorphisms in myasthenia gravis
G O Skeie1, J P Pandey, J A Aarli
1Department of Neurology, Haukeland Hospital, University of Bergen, Norway.
Archives of Neurology
|April 13, 1999
Summary
Tumor necrosis factor (TNF) gene polymorphisms are linked to myasthenia gravis (MG) subtypes. Specific TNF alleles correlate with thymoma, early-onset disease, and the presence or absence of titin antibodies in MG patients.
Area of Science:
- Immunogenetics
- Autoimmune Diseases
- Molecular Biology
Background:
- Proinflammatory cytokines, Tumor Necrosis Factor (TNF) alpha and TNF-beta, are implicated in myasthenia gravis (MG) pathogenesis.
- Understanding the genetic basis of MG is crucial for targeted therapies.
Purpose of the Study:
- To investigate the association between TNF polymorphisms and MG.
- To explore correlations with specific MG subgroups, including thymoma presence.
- To examine links with titin and ryanodine-receptor antibodies in MG patients.
Main Methods:
- Genotyping of 30 MG patients and 92 healthy controls.
- Analysis of two TNFA polymorphisms (-238 and -308) and one TNFB polymorphism.
- Utilized polymerase chain reaction-based methods for genotyping.
Main Results:
- Patients with thymoma or titin antibodies frequently showed homozygous TNFA*T1 and TNFB*2 alleles.
- Early-onset MG without thymoma was associated with TNFA*T2 and TNFB*1 alleles.
- No significant association found between TNF polymorphisms and acetylcholine-receptor levels or disease severity.
Conclusions:
- Specific TNF polymorphisms are associated with distinct clinical phenotypes in myasthenia gravis.
- TNFA*T1/TNFB*2 alleles are linked to thymoma and titin antibody presence.
- TNFA*T2/TNFB*1 alleles correlate with early-onset MG and absence of titin antibodies.